nimodipine has been researched along with Affective Disorders in 4 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Forty three patients with chronic alcoholism of stage II with secondary affective disorders (anxiety, subdepression) and actualization of pathological drive for alcohol in remission period were divided into 3 groups: patients were treated with nimodipine (90 mg/day during 10 days), patients were treated with nifedipine (45 mg/day during 10 days) and patients of control group (they received a placebo for 10 days)." | 5.11 | [The efficacy of calcium channel blockers in the treatment of affective disorders and pathologic drive for alcohol in patients with alcoholism in the remission period]. ( Burakov, AM; Grinenko, AIa; Karandashova, GF; Krupitskiĭ, EM; Priputina, LS; Romanova, TN; Slavina, TIu; Vostrikov, VV, 2004) |
| "Preliminary evidence suggests that nimodipine, an L-type calcium channel blocker, is effective in treating some patients with rapidly cycling affective disorders and some phases of Alzheimer's disease, i." | 5.08 | Nimodipine increases CSF somatostatin in affectively ill patients. ( Davis, CL; George, MS; Pazzaglia, PJ; Post, RM; Rubinow, DR, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frye, MA | 1 |
| Pazzaglia, PJ | 2 |
| George, MS | 2 |
| Luckenbaugh, DA | 1 |
| Vanderham, E | 1 |
| Davis, CL | 2 |
| Rubinow, DR | 2 |
| Post, RM | 2 |
| Krupitskiĭ, EM | 1 |
| Burakov, AM | 1 |
| Priputina, LS | 1 |
| Vostrikov, VV | 1 |
| Romanova, TN | 1 |
| Karandashova, GF | 1 |
| Slavina, TIu | 1 |
| Grinenko, AIa | 1 |
| Goodnick, PJ | 1 |
3 trials available for nimodipine and Affective Disorders
| Article | Year |
|---|---|
Low CSF somatostatin associated with response to nimodipine in patents with affective illness.
Topics: Adult; Calcium Channel Blockers; Double-Blind Method; Female; Humans; Male; Mood Disorders; Nimodipi | 2003 |
[The efficacy of calcium channel blockers in the treatment of affective disorders and pathologic drive for alcohol in patients with alcoholism in the remission period].
Topics: Adult; Alcoholism; Calcium Channel Blockers; Double-Blind Method; Drive; Humans; Mood Disorders; Nif | 2004 |
Nimodipine increases CSF somatostatin in affectively ill patients.
Topics: Adult; Bipolar Disorder; Calcium Channel Blockers; Female; Humans; Male; Middle Aged; Mood Disorders | 1995 |
1 other study available for nimodipine and Affective Disorders
| Article | Year |
|---|---|
The use of nimodipine in the treatment of mood disorders.
Topics: Activity Cycles; Bipolar Disorder; Calcium Channel Blockers; Catecholamines; Humans; Mood Disorders; | 2000 |